Bring the exact product name, website claims, ingredient list, label wording, and any testing certificate to a clinician or pharmacist
Recent reviews (March 2026) consistently praise the welcome calls from team members
[13] [14] UK SmPCs for licensed GLP-1 receptor agonists do not list medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) as formal contraindications, but advise vigilance for symptoms such as a neck lump, hoarseness, or difficulty swallowing
& Germanidis, G
[DOI] [PMC free article] [PubMed] [Google Scholar] 51
They should also call if nausea worsens after a dose increase, continues beyond the expected adjustment period, or is paired with vomiting, dizziness, abdominal pain, or dehydration